Emcure Pharmaceuticals partners with Sanofi India to distribute and promote oral anti-diabetic products in India.

Emcure Pharmaceuticals Ltd. and Sanofi India Limited today entered into an exclusive distribution and promotion agreement for ...

KPRDO acknowledges Emcure’s positive response on exclusive stockist appointment for special category sales: Nandita ...

Emcure Pharmaceuticals and Sanofi India have entered in a partnership to distribute and promote Sanofi’s oral anti-diabetic ...

Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...

Over 100 million Indians are living with type 2 diabetes and its complexities in India,' said Eric Mansion from Sanofi.

Emcure Pharmaceuticals Limited announced the appointment of Mr. R.S. Vasan as President - India Business and Senior ...

Emcure Pharmaceuticals and Sanofi India announce exclusive distribution agreement for Sanofi's oral anti-diabetic products in ...

Emcure Pharmaceuticals and Sanofi India have announced a distribution agreement. Emcure will promote Sanofi India's oral anti ...

Q2 2025 saw deal value drop 62% as large-ticket M&A dried up; investors pivot to focused platforms in pharma, hospitals, ...

Emcure Pharma and Sanofi India announced that they entered into an exclusive distribution and promotion agreement for the latter's oral anti-diabetic products in India, effective immediately. Emcure ...

The NSE Nifty 50 ended 16.25 points or 0.06% higher at 25,212.05, while the BSE Sensex closed 63.57 points or 0.08% up at 82,634.48.